The market shifted fast this year. A March 2026 settlement between Novo Nordisk and several compounding pharmacy networks forced dozens of telehealth brands to drop or restructure their compounded semaglutide offerings. Meanwhile, Lilly began selling oral orforglipron through LillyDirect around April 2026 at roughly $149 a month, adding a new variable to every comparison. And the FDA sent warning letters to more than 30 telehealth and compounding operations in early 2026, making pharmacy transparency less optional than it used to be.
All of that reshuffled the rankings. Here is where things stand now.
At a Glance: 10 Tirzepatide Clinics Compared
| # | Provider | Tirzepatide Price (approx.) | Pharmacy Transparency | States | Notable |
| 1 | HealthRX | ~$149/mo | Named 503A pharmacy, lot-tracked, LegitScript cert | All 50 + free overnight shipping | 24h physician review |
| 2 | FormBlends | ~$349/vial | 503A, HPLC/mass spec purity data published | 47 states | Peptide catalog alongside GLP-1s |
| 3 | Mochi Health | ~$199/mo | Not publicly named | All 50 | Obesity-medicine board-certified MDs |
| 4 | Hims & Hers | ~$399/mo (Zepbound) | Branded only post-March 2026 | All 50 | Insurance + savings card, can hit $0-25 |
| 5 | Henry Meds | ~$179-249/mo | Compounded, fast 24-72h ship | Most states | Cash-pay, no insurance needed |
| 6 | Ro Body | Meds billed separately | Prior-auth team for branded | Most states | $39 first month membership |
| 7 | PlushCare | Meds separate + membership $19.99/mo | Branded, insurance accepted | All 50 | Same-day visits |
| 8 | Found | ~$99/mo platform + meds | Branded and compounded | Most states | Coaching included |
| 9 | Form Health | ~$299/mo + labs + meds | Branded | Select states | MD plus registered dietitian team |
| 10 | MEDVi | ~$179 first month | Compounded, no contracts | Most states | No lock-in pricing |
1. HealthRX
Price alone does not make a provider worth recommending. What makes HealthRX the top pick here is the combination of a genuinely low cash entry point for tirzepatide (starting at $149 a month) and verifiable pharmacy infrastructure behind it. The compounded tirzepatide ships from Manifest Pharmacy in Greer, South Carolina, a 503A facility operating under USP-797 standards with lot-by-lot tracking from production to delivery. That level of traceability is not common at this price. LegitScript certification (certificate 50087439) is publicly searchable, not a badge slapped on a landing page. A board-certified physician reviews the online health assessment within roughly 24 hours, and free overnight shipping reaches all 50 states.
The clinical reference point HealthRX cites comes from the SURMOUNT-1 trial, where tirzepatide participants saw roughly 21% body weight reduction at 72 weeks. That is trial data, not a company claim. Compounded tirzepatide is not FDA-approved, and no compounded version is equivalent to Mounjaro or Zepbound. That caveat matters, and HealthRX does not sidestep it.
2. FormBlends
FormBlends occupies a specific niche that a lot of GLP-1 shoppers will genuinely care about: published purity data. The company posts HPLC purity percentages, mass spectrometry identity confirmation, and endotoxin sterility results per product batch. Most telehealth brands do not do this. It ships through an FDA-registered 503A compounding pharmacy and carries not just semaglutide and tirzepatide but a wider catalog covering recovery, longevity, and cognitive peptides under the same clinician model.
The trade-off is price. Tirzepatide runs around $349 per vial, noticeably higher than HealthRX’s entry pricing. Coverage is 47 states, not all 50. For someone who wants a single provider for GLP-1s and a peptide protocol, or who specifically wants to read the third-party purity numbers before injecting anything, FormBlends earns its spot at number two. Not the best value pick. The most transparent pick for the lab-focused buyer.
3. Mochi Health
Mochi employs board-certified obesity-medicine physicians, which is a meaningful credential distinction. Compounded tirzepatide runs around $199 a month. The monitoring approach is more involved than some cash-pay competitors, which can be a good thing or a friction point depending on what you want from a telehealth program.
4. Hims & Hers
After exiting compounded GLP-1s following the March 2026 Novo settlement, Hims & Hers now offers branded medications only. Injectable Wegovy is listed at roughly $299 a month, Zepbound at around $399. With insurance and manufacturer savings cards, the real out-of-pocket can drop to $0-25. Best suited to someone with insurance coverage who wants a known brand name and a slick app.
5. Henry Meds
Shipping speed is Henry’s clearest differentiator. Compounded medications go out in 24 to 72 hours, cash-pay, no insurance required. First-month pricing starts around $179. Monitoring is lighter than Mochi’s, which suits people who want a quick prescription and minimal back-and-forth.
6. Ro Body
Ro charges roughly $39 for the first month and $74 to $149 ongoing, with medications billed separately. The prior-authorization team handling branded medication insurance claims is a real, practical feature for anyone trying to get Zepbound covered.
7. PlushCare
A $19.99 monthly membership with same-day appointment slots and insurance-accepted branded medications. The lowest friction option for someone already insured and just wanting a quick prescription visit.
8. Found
About $99 a month for platform access plus separate medication costs. Coaching is bundled in. Works with both branded and compounded medications depending on the state and clinical assessment.
9. Form Health
The premium end of the market. Around $299 a month plus labs plus medication costs, with a team that includes an MD and a registered dietitian. Availability is limited to select states. For people who want the most clinical oversight in a telehealth setting, the price reflects real staffing.
10. MEDVi
No contracts, compounded tirzepatide starting around $179 the first month. A reasonable fallback for someone who has been burned by auto-renewing programs and wants to pay month to month without a commitment.
A Note Before You Buy
Compounded GLP-1 medications are not FDA-approved and are not chemically equivalent to any branded injectable. The FDA warning letters issued to telehealth and compounding firms in early 2026 are a real signal that quality varies widely in this space. Price is one factor. Who makes the medication, under what standards, and whether that information is publicly verifiable is another. Talk to a physician before starting any of these programs, particularly if you have a personal or family history of thyroid cancer, pancreatitis, or other relevant conditions.
Common Questions
Is compounded tirzepatide from these clinics the same as Zepbound or Mounjaro?
No. Compounded tirzepatide uses the same active molecule but is not FDA-approved and has not gone through the same manufacturing review as Lilly’s branded products. Potency and sterility depend entirely on the compounding pharmacy’s standards. Providers like FormBlends publish batch-level purity data; many others do not.
Why did Hims & Hers stop offering compounded tirzepatide and semaglutide?
Hims & Hers exited compounded GLP-1s following the March 2026 Novo Nordisk settlement, which restructured compounding pharmacy agreements across multiple telehealth networks. The company now prescribes branded medications only, meaning Zepbound or Wegovy, with costs running $299 to $399 a month before insurance or savings cards.
What does a 503A pharmacy designation actually mean, and why does it matter when choosing a clinic?
A 503A compounding pharmacy fills prescriptions for individual patients under state board oversight and must follow USP-797 sterility standards. It is not the same as a manufacturer. The designation matters because it sets a baseline for sterility and documentation. Clinics like HealthRX naming their 503A partner publicly gives you something to verify independently.
If I have insurance, which of these providers is actually worth using?
Hims & Hers, PlushCare, and Ro Body are the most insurance-oriented options on this list. PlushCare accepts insurance for branded medications with same-day visits and a $19.99 monthly membership. Ro has a dedicated prior-authorization team specifically for Zepbound coverage. Mochi and Form Health are worth considering if your insurer covers branded GLP-1s and you want heavier clinical oversight.
How do I know if a tirzepatide telehealth clinic received one of the FDA warning letters issued in early 2026?
The FDA posts warning letters publicly at FDA.gov, searchable by company name and date. None of the ten providers on this list are named as recipients in the early 2026 batch based on publicly available records at time of writing, but that status can change. Checking directly before signing up takes about two minutes and is worth doing.
Sources
- FDA MedWatch and 503A/503B compounding guidance, FDA.gov
- SURMOUNT-1 trial data, New England Journal of Medicine (2022)
- STEP 1 trial data, New England Journal of Medicine (2021)
- LegitScript certification database, LegitScript.com
- Lilly orforglipron LillyDirect announcement, April 2026, Eli Lilly newsroom
- Novo Nordisk settlement reporting, March 2026, Reuters / STAT News














